Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Oriental Aromatics Ltd (OAL)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 500078 NSE: OAL Chemicals | Small Cap | Oriental Aromatics Share Price
₹530.65 0.15 (0.03%)
As on 28-Sep'26 10:17
Oriental Aromatics Ltd (OAL)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 500078 NSE: OAL Chemicals | Small Cap | Oriental Aromatics Share Price
₹530.65 0.15 (0.03%)
As on 28-Sep'26 10:17
Key Metrics
Valuation Multiples
Market Cap
₹1,785 Cr.
Current Price
₹530.7
52-Week Low / High
₹227 / 572
TTM EPS
₹1.6
TTM Sales
₹1,065 Cr.
Book Value per Share
₹198.2
P/E Ratio
335.59
Higher than its 5-year historical median
Industry PE
48
Price to Book (P/B)
2.68
Higher than its 5-year historical median
Price to Sales (P/S)
1.68
Higher than its 5-year historical median
EV/EBITDA
27.14
Higher than its 5-year historical median
Dividend Yield
0.09%
Profitability Efficiency
Return on Equity (ROE)
0.50%
Underperforms industry median
Return on Capital Employed (ROCE)
4.47%
Underperforms industry median
Return on Assets (ROA)
0.28%
Operating Profit Margin
6.6%
Net Profit Margin
0.32%
Gross Profit Margin
4%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
10.52%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
-26.11%
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
-90.36%
Asset Quality
Promoter Holding
74.17%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹650 Cr.
Equity
₹16.8 Cr.
Face Value
₹5
All Time Low / High
₹3.55 / 1148.00
Check Before You Invest
Quality
Not GoodValuation
FairCheck Valuation charts
Price Trend
Strong
Is Oriental Aromatics Ltd a good quality company?
Oriental Aromatics Ltd is a weak quality company, based on a inconsistent multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Oriental Aromatics Ltd performance compare with that of its Peers?
Revenue growth of Oriental Aromatics Ltd vs industry peers?
Oriental Aromatics Ltd revenue CAGR is 7.78%, compared to the industry median CAGR of 0%, indicating faster growth and gaining its market share.
Promoter shareholding and pledge status of Oriental Aromatics Ltd?
Promoters hold 74.17% of the Oriental Aromatics Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Oriental Aromatics Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 10.8% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Oriental Aromatics Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Value Creation ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 13.5% | 12.5% | 16.9% | 21.2% | 24.3% | 11.7% | 5.2% | 4.2% | 9.3% | 6.3% | - |
| Value Creation Index ⓘ | 0.0 | -0.1 | 0.2 | 0.5 | 0.7 | -0.2 | -0.6 | -0.7 | -0.3 | -0.6 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 456 | 506 | 753 | 759 | 709 | 869 | 849 | 836 | 928 | 1,026 | 1,057 |
| Sales YoY Gr. | - | 11% | 48.8% | 0.9% | -6.7% | 22.6% | -2.3% | -1.5% | 11% | 10.5% | - |
| Adj EPS ⓘ | 12.3 | 8.9 | 17.2 | 24.6 | 30.4 | 15.7 | 5.4 | 1.5 | 13.3 | 5.8 | 8.2 |
| YoY Gr. | - | -27.6% | 93.7% | 43% | 23.7% | -48.5% | -65.4% | -72.5% | 794.6% | -56.5% | - |
| BVPS (₹) ⓘ | 153.6 | 102.4 | 116.5 | 137.8 | 165.7 | 180.1 | 186.2 | 188.5 | 201.7 | 208.6 | 211.1 |
| Adj Net Profit ⓘ | 25.2 | 29.8 | 57.8 | 82.6 | 102 | 52.7 | 18.2 | 5 | 44.9 | 19.5 | 28 |
| Cash Flow from Ops. ⓘ | 39.4 | 9.5 | -24 | 185 | 18.6 | -1.1 | -21.3 | 153 | -18.5 | 33.2 | - |
| Debt/CF from Ops. ⓘ | 2.5 | 13.8 | -7.7 | 0.3 | 4.2 | -126 | -10.8 | 1.1 | -15.1 | 9.8 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 9.4% | 7.7% | 6.5% | 10.5% | ||||
| Adj EPS ⓘ | -8% | -28.2% | 2.3% | -56.5% | ||||
| BVPSⓘ | 3.5% | 4.7% | 3.9% | 3.5% | ||||
| Share Price | 10.8% | -10.2% | 14.2% | 57.9% | ||||
Key Financial Parameters ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 10.6 | 9 | 15.7 | 19.3 | 20 | 9.1 | 3 | 0.8 | 6.8 | 2.8 | 3.9 |
| Op. Profit Mgn % ⓘ | 12.8 | 13 | 15.5 | 16.9 | 22.1 | 10.8 | 6.5 | 5.7 | 10.7 | 7.6 | 7.6 |
| Net Profit Mgn % ⓘ | 5.5 | 5.9 | 7.7 | 10.9 | 14.4 | 6.1 | 2.2 | 0.6 | 4.8 | 1.9 | 2.6 |
| Debt to Equity ⓘ | 0.3 | 0.4 | 0.5 | 0.1 | 0.1 | 0.2 | 0.4 | 0.3 | 0.4 | 0.5 | - |
| Working Cap Days ⓘ | 193 | 211 | 179 | 185 | 210 | 216 | 257 | 264 | 237 | 235 | 112 |
| Cash Conv. Cycle ⓘ | 117 | 132 | 120 | 131 | 146 | 153 | 185 | 181 | 166 | 173 | 44 |
Valuation of Oriental Aromatics - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 458 | 506 | 755 | 760 | 709 | 869 | 849 | 836 | 928 | 1,031 |
| Operating Expenses ⓘ + | 401 | 442 | 640 | 633 | 554 | 776 | 795 | 789 | 836 | 963 |
| Operating Profit ⓘ | 57 | 64 | 115 | 127 | 155 | 93 | 54 | 47 | 92 | 68 |
| Operating Profit Margin (%) | 12.4% | 12.7% | 15.2% | 16.7% | 21.9% | 10.7% | 6.4% | 5.6% | 9.9% | 6.6% |
| Other Income ⓘ + | 8 | 2 | 1 | 7 | 2 | 4 | 6 | 7 | 4 | 10 |
| Interest ⓘ | 6 | 8 | 13 | 12 | 2 | 4 | 13 | 20 | 25 | 36 |
| Depreciation ⓘ | 14 | 15 | 18 | 19 | 17 | 17 | 19 | 20 | 24 | 31 |
| Profit Before Tax ⓘ | 44 | 43 | 83 | 103 | 137 | 76 | 27 | 14 | 48 | 11 |
| Tax ⓘ | 16 | 18 | 26 | 17 | 35 | 23 | 8 | 5 | 13 | 7 |
| Profit After Tax | 28 | 25 | 57 | 86 | 102 | 53 | 20 | 9 | 34 | 3 |
| PAT Margin (%) | 6.1% | 4.9% | 7.6% | 11.3% | 14.4% | 6.1% | 2.3% | 1.1% | 3.7% | 0.3% |
| Adjusted EPS (₹) | 13.6 | 7.4 | 17.0 | 25.6 | 30.3 | 15.8 | 5.9 | 2.7 | 10.2 | 1.0 |
| Dividend Payout Ratio (%) | 2.80% | 6.70% | 5.90% | 9.80% | 8.30% | 9.50% | 8.50% | 18.50% | 4.90% | 50.80% |
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 313 | 338 | 392 | 464 | 557 | 605 | 625 | 632 | 663 | 665 | |
| Debt + | 105 | 122 | 174 | 45 | 78 | 134 | 215 | 191 | 338 | 385 | |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Trade Payables | 33 | 61 | 54 | 56 | 71 | 81 | 87 | 82 | 76 | 83 | |
| Others Liabilities ⓘ | 39 | 52 | 54 | 44 | 39 | 44 | 59 | 90 | 69 | 62 | |
| Total Liabilities ⓘ | 490 | 573 | 673 | 608 | 745 | 865 | 986 | 995 | 1,145 | 1,194 | |
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 211 | 212 | 245 | 236 | 236 | 265 | 273 | 270 | 480 | 460 | |
| CWIP ⓘ | 15 | 40 | 1 | 2 | 13 | 25 | 53 | 173 | 5 | 5 | |
| Investments ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Inventories | 114 | 133 | 203 | 162 | 228 | 287 | 368 | 277 | 365 | 380 | |
| Trade Receivables | 100 | 134 | 160 | 151 | 189 | 195 | 190 | 181 | 188 | 252 | |
| Cash Equivalents | 6 | 6 | 6 | 21 | 20 | 9 | 17 | 12 | 12 | 15 | |
| Others Assets ⓘ | 44 | 48 | 58 | 35 | 60 | 83 | 86 | 82 | 95 | 83 | |
| Total Assets ⓘ | 490 | 573 | 673 | 608 | 745 | 865 | 986 | 995 | 1,145 | 1,194 | |
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 0 | 16 | -23 | 181 | 17 | -1 | -22 | 142 | -34 | 2 |
| Cash Flow From Investing Activity ⓘ + | 0 | -31 | -12 | -10 | -35 | -59 | -46 | -99 | -87 | -12 |
| Cash Flow From Financing Activity ⓘ + | 0 | 15 | 36 | -159 | 16 | 51 | 78 | -48 | 121 | 12 |
| Net Cash Flow ⓘ | 0 | 0 | 0 | 12 | -2 | -9 | 9 | -5 | -0 | 3 |
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 8.9 | 7.68 | 15.67 | 20.14 | 19.96 | 9.17 | 3.21 | 1.45 | 5.3 | 0.5 |
| ROCE (%) | 11.97 | 11.4 | 18.41 | 21.06 | 24.22 | 11.59 | 5.07 | 4.07 | 7.86 | 4.47 |
| Asset Turnover Ratio | 0.93 | 0.95 | 1.22 | 1.19 | 1.05 | 1.08 | 0.92 | 0.85 | 0.87 | 0.89 |
| PAT to CFO Conversion(x) | 0 | 0.64 | -0.4 | 2.1 | 0.17 | -0.02 | -1.1 | 15.78 | -1 | 0.67 |
| Working Capital Days | ||||||||||
| Receivable Days | 79.80 | 84.60 | 70.90 | 74.50 | 87.10 | 80.20 | 82.30 | 80.30 | 72 | 77.50 |
| Inventory Days | 91.30 | 89.20 | 80.80 | 87.30 | 99.90 | 107.60 | 140 | 139.70 | 125.30 | 130.90 |
| Payable Days | 40.60 | 52.50 | 42.10 | 41.70 | 58.50 | 48.40 | 53.20 | 53.90 | 51.50 | 42.40 |
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Oriental Aromatics Ltd FAQs
The current trading price of Oriental Aromatics on 28-Sep-2026 10:17 is ₹530.6.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 27-Sep-2026 the market cap of Oriental Aromatics stood at ₹1,785.3 Cr
The latest P/E ratio of Oriental Aromatics as of 27-Sep-2026 is 64.50.
The latest P/B ratio of Oriental Aromatics as of 27-Sep-2026 is 2.51.
The 52-week high of Oriental Aromatics is ₹572.0 and the 52-week low is ₹227.1.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Oriental Aromatics is ₹1,057 ( Cr.) .
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Oriental Aromatics Ltd is a below average quality company.
The key valuation ratios of Oriental Aromatics Ltd's currently when compared to its past seem to suggest it is in the Fair zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Oriental Aromatics Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing
About Oriental Aromatics Ltd
Camphor & Allied Products Ltd incorporated in 1961 is India’s largest manufacturers of variety of terpene chemicals and other speciality aroma chemicals. Its vast product range includes synthetic camphor, terpineols, pine oils, resins, astrolide, dihydromyrcenol, and several other chemicals finding applications in vast array of industries ranging from flavours & fragrances, pharmaceuticals, soaps & cosmetics, rubber & tyre, paints & varnishes and many more.
It is a pioneer in the field of terpene chemistry in India since 1964, having established the first synthetic camphor plant with technology from DuPont of USA. The plant of the company is located at Bareilly in West Uttar Pradesh, 250 km from New Delhi. It handles a volume of 20,000 tons of raw materials and finished products annually and incorporates the latest technology and equipment.
The company carries out all conceivable chemical operations such as fractionation, esterification, saponification, hydrogenation, dehydrogenation, oxidation, peroxidation, pyrolysis, etc. in the plant using equipment and technology that is constantly updated with time to keep pace with the latest advancements in chemistry and chemical engineering practices.
Its vast product range includes synthetic camphor (all grades), terpineols, pine oils, Isobornyl acetate, terpene resins and many more. All processes are monitored by well-trained technical personnel with the help of latest instrumentation and quality control.
The company is also having a state-of-the-art manufacturing facility that was set up at Nandesari, Baroda in 1999, to manufacture high value fragrance chemicals and fragrance chemical intermediates based on in-house technology. Products manufactured at this plant are of international standard and are well accepted in markets abroad and at home.
Product range of the company includes:
- Fragrance Chemicals
- Pharmaceutical Products
- Aromatic Chemicals
- Industrial Chemicals
You have 44 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
